计算框架拟整合阿尔茨海默病多层数据,或助力个体化医疗
Proposed computer framework could connect Alzheimer's data to guide personalized care
研究人员在 Brain 提出一种元建模计算框架,拟整合阿尔茨海默病的认知症状、脑影像、生物标志物、遗传和风险因素等多层数据,构建个体化疾病画像。该框架尚属未来研究提案,尚未成为临床工具,需更大规模、更多样化数据和重复验证。若开发验证成功,或有助于预测疾病进展、识别亚型并比较不同干预下的疾病轨迹。
Alzheimer's disease may not be a single, uniform condition, but a complex disorder shaped by different combinations of cognitive symptoms, brain changes, biology, genetics and risk factors. A team of researchers propose using advanced computational modeling to bring these different layers together and build a more complete profile of each patient. The approach could eventually support more personalized diagnosis, better patient stratification and treatments tailored to the processes driving disease in each individual.
Their new paper published in Brain, led by professor Shahar Arzy (Faculty of Medicine), Dr. Bark Raveh (computer science) and professor Gad Marshall (Harvard Medical School), suggests that a novel computational approach may enable doctors to decipher the disease's complex nature and tailor preventive interventions to the individual long before symptoms appear.
Rather than searching for a single explanation that applies equally to every patient, the computational era may allow researchers to embrace the disease's complexity, identifying the different pathways that can lead to cognitive decline and ultimately moving toward diagnosis and treatment tailored to the individual.
The researchers point out that people diagnosed with Alzheimer's do not necessarily experience the same symptoms, show the same patterns of changes in the brain or share the same biological and genetic basis. In some people, memory loss may dominate, while others may experience problems with orientation, language, behavior, visual processing or executive functions. At the same time, the biological processes associated with Alzheimer's extend beyond the two proteins most commonly linked to the disease, amyloid and tau. Inflammatory, vascular, metabolic, infectious, toxic and other brain pathologies also make important contributions.
"This means that two people who receive the same diagnosis of Alzheimer's disease may actually be experiencing very different combinations of biological and cognitive changes," said Arzy. "Instead of looking for a single explanation that fits every patient, we need to understand the individual profile of the disease. The computational tools now available give us an opportunity to bring these different pieces together and ultimately move toward more personalized diagnosis and treatment."
From one diagnosis to an individual profile
Rather than asking only whether a person "has Alzheimer's," the researchers propose building a much more detailed picture of each patient. Such a profile could combine information about cognitive and behavioral symptoms with brain imaging, biomarkers, genetics, molecular data, risk factors and the way the disease changes over time.
The goal is similar to the shift toward precision medicine already taking place in other areas of health care: understanding which processes are driving the disease in a particular person. To make that possible, the researchers outline a computational approach known as metamodeling.
Instead of trying to build a single enormous computer model from scratch and squeezing every piece of information about Alzheimer's into it, the approach makes use of existing and newly built separate, more specialized models, each examining one or more aspects of the disease. One might focus on brain imaging, another on genetics, another on specific molecular changes and another on certain cognitive, behavioral or neuropsychiatric symptoms. These models could then be mathematically connected to create an integrative approach to the multifaceted nature of the disease.
In simpler terms, it is an attempt to computationally assemble many different pieces of the Alzheimer's puzzle by unifying the enormous body of work produced over a century of research into a single, inclusive metamodel.
Could computers help predict an individual patient's future?
If successfully developed and validated, such a framework could eventually help researchers estimate how Alzheimer's is likely to progress in a particular patient, identify different disease patterns or subtypes and investigate which biological processes may be most important in that individual.
It could also allow scientists to model possible interventions and compare predicted disease trajectories with and without a particular treatment.
This could have implications for clinical trials as well. Most trials currently compare groups of patients and often target a particular biological process. A more integrated model could potentially help doctors and researchers identify groups of patients who share similar disease mechanisms and determine which treatments are most appropriate to test in each group.
The proposal remains a framework for future research rather than a tool ready for use in the clinic. Building it would require much larger and more diverse data sets, repeated testing and collaboration across the Alzheimer's research community. Still, it points toward a significant change in how Alzheimer's could eventually be approached.
Publication details
Meitar Benbaji et al., Alzheimer's disease in the computational era: from a deterministic disease to a multifaceted disorder, Brain (2026). DOI: 10.1093/brain/awag248
Journal information: Brain
Clinical categories
Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Proposed computer framework could connect Alzheimer's data to guide personalized care (2026, October 19) retrieved 19 October 2026 from https://medicalxpress.com/news/2026-10-framework-alzheimer-personalized.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com